BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31701087)

  • 1. Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution.
    Haas JT; Vonghia L; Mogilenko DA; Verrijken A; Molendi-Coste O; Fleury S; Deprince A; Nikitin A; Woitrain E; Ducrocq-Geoffroy L; Pic S; Derudas B; Dehondt H; Gheeraert C; Van Gaal L; Driessen A; Lefebvre P; Staels B; Francque S; Dombrowicz D
    Nat Metab; 2019 Jun; 1(6):604-614. PubMed ID: 31701087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis.
    Van Herck MA; Vonghia L; Kwanten WJ; Julé Y; Vanwolleghem T; Ebo DG; Michielsen PP; De Man JG; Gama L; De Winter BY; Francque SM
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):467-490. PubMed ID: 32360637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XCR1
    Deczkowska A; David E; Ramadori P; Pfister D; Safran M; Li B; Giladi A; Jaitin DA; Barboy O; Cohen M; Yofe I; Gur C; Shlomi-Loubaton S; Henri S; Suhail Y; Qiu M; Kam S; Hermon H; Lahat E; Ben Yakov G; Cohen-Ezra O; Davidov Y; Likhter M; Goitein D; Roth S; Weber A; Malissen B; Weiner A; Ben-Ari Z; Heikenwälder M; Elinav E; Amit I
    Nat Med; 2021 Jun; 27(6):1043-1054. PubMed ID: 34017133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
    Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
    Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
    Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
    Front Immunol; 2020; 11():563434. PubMed ID: 33391254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
    Barrow F; Khan S; Fredrickson G; Wang H; Dietsche K; Parthiban P; Robert S; Kaiser T; Winer S; Herman A; Adeyi O; Mouzaki M; Khoruts A; Hogquist KA; Staley C; Winer DA; Revelo XS
    Hepatology; 2021 Aug; 74(2):704-722. PubMed ID: 33609303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auto-aggressive CXCR6
    Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
    Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin treatment rescues CD8
    Wabitsch S; McCallen JD; Kamenyeva O; Ruf B; McVey JC; Kabat J; Walz JS; Rotman Y; Bauer KC; Craig AJ; Pouzolles M; Phadke I; Catania V; Green BL; Fu C; Diggs LP; Heinrich B; Wang XW; Ma C; Greten TF
    J Hepatol; 2022 Sep; 77(3):748-760. PubMed ID: 35378172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
    Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
    Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.